- Home
- GVA vs SWTX Comparison
GVA vs SWTX Comparison
Compare GVA & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVA
- SWTX
- Stock Information
- Founded
- GVA 1922
- SWTX 2017
- Country
- GVA United States
- SWTX United States
- Employees
- GVA N/A
- SWTX N/A
- Industry
- GVA Military/Government/Technical
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- GVA Industrials
- SWTX Health Care
- Exchange
- GVA Nasdaq
- SWTX Nasdaq
- Market Cap
- GVA 3.3B
- SWTX 3.0B
- IPO Year
- GVA 1990
- SWTX 2019
- Fundamental
- Price
- GVA $77.25
- SWTX $37.92
- Analyst Decision
- GVA Strong Sell
- SWTX Strong Buy
- Analyst Count
- GVA 1
- SWTX 5
- Target Price
- GVA $70.00
- SWTX $72.40
- AVG Volume (30 Days)
- GVA 744.5K
- SWTX 2.2M
- Earning Date
- GVA 05-01-2025
- SWTX 05-01-2025
- Dividend Yield
- GVA 0.67%
- SWTX N/A
- EPS Growth
- GVA 169.33
- SWTX N/A
- EPS
- GVA 2.62
- SWTX N/A
- Revenue
- GVA $4,007,574,000.00
- SWTX $191,589,000.00
- Revenue This Year
- GVA $8.05
- SWTX $85.98
- Revenue Next Year
- GVA $6.10
- SWTX $69.16
- P/E Ratio
- GVA $29.44
- SWTX N/A
- Revenue Growth
- GVA 14.20
- SWTX 3417.33
- 52 Week Low
- GVA $53.00
- SWTX $28.21
- 52 Week High
- GVA $105.20
- SWTX $62.00
- Technical
- Relative Strength Index (RSI)
- GVA 51.05
- SWTX 39.33
- Support Level
- GVA $76.25
- SWTX $36.08
- Resistance Level
- GVA $79.89
- SWTX $38.77
- Average True Range (ATR)
- GVA 3.43
- SWTX 3.21
- MACD
- GVA 0.56
- SWTX -0.17
- Stochastic Oscillator
- GVA 75.58
- SWTX 36.05
About GVA Granite Construction Incorporated
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.